• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用人工智能替代检查时间评估食管胃十二指肠镜检查的完整性:一项前瞻性、随机、非劣效性研究

Artificial Intelligence as a Surrogate for Inspection Time to Assess Completeness in Esophagogastroduodenoscopy: A Prospective, Randomized, Noninferiority Study.

作者信息

Tan Xia, Yao Liwen, Dong Zehua, Li Yanxia, Yu Yuanjie, Gao Xin, Zhu Kai, Su Wenhao, Yin Haisen, Wang Wen, Luo Chaijie, Li Jialing, You Hang, Hu Huiyan, Zhou Wei, Yu Honggang

机构信息

Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China.

Hubei Provincial Clinical Research Center for Digestive Disease Minimally Invasive Incision, Renmin Hospital of Wuhan University, Wuhan, China.

出版信息

Clin Transl Gastroenterol. 2025 Mar 25;16(6):e00839. doi: 10.14309/ctg.0000000000000839. eCollection 2025 Jun 1.

DOI:10.14309/ctg.0000000000000839
PMID:40125855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12180831/
Abstract

INTRODUCTION

The completeness of esophagogastroduodenoscopy (EGD) is a prerequisite for detecting lesions. This study aims to explore whether the quality of complete examinations assisted by artificial intelligence (AI) would be comparable with those conducted within the guideline-recommended inspection time.

METHODS

Patients referred for diagnostic, screening, or surveillance EGD were enrolled at Renmin Hospital of Wuhan University. Patients were randomly assigned to 2 groups in a 1:1 ratio. In the AI-assisted group, endoscopists completed observation of the entire upper gastrointestinal tract with AI assistance. In the control group, endoscopists were instructed to spend no less than 7 minutes on each procedure. The primary outcome was the detection rate of neoplastic lesions. Noninferiority was confirmed when the lower bound of the 95% confidence interval (CI) was greater than the margin of -1.5%.

RESULTS

A total of 1,723 patients were prospectively enrolled between July 3, 2023, and April 7, 2024. Seven hundred ninety-six and 763 patients in the AI-assisted and control groups were included in the final analysis, respectively. The detection rates of neoplastic lesions in the AI-assisted and control groups were 3.14% and 2.36%, respectively, resulting in an absolute proportion difference of 0.78% (95% CI -0.58% to 2.14%; odds ratio 1.342 [95% CI 0.726-2.480]). The median inspection time was reduced by 1.5 minutes in the AI-assisted group (6.18 [2.87] vs 7.70 [1.90], P < 0.001).

DISCUSSION

Inspection time of complete EGD can be significantly shortened by AI without compromising its quality. These findings provide crucial evidence to support that AI-assisted procedural completeness serves as an objective and effective quality indicator for EGD.

摘要

引言

食管胃十二指肠镜检查(EGD)的完整性是检测病变的前提条件。本研究旨在探讨人工智能(AI)辅助下的完整检查质量是否与在指南推荐的检查时间内进行的检查质量相当。

方法

武汉大学人民医院招募了因诊断、筛查或监测EGD而就诊的患者。患者按1:1的比例随机分为两组。在AI辅助组中,内镜医师在AI的辅助下完成对上消化道的全面观察。在对照组中,指示内镜医师在每个操作上花费不少于7分钟。主要结局是肿瘤性病变的检出率。当95%置信区间(CI)的下限大于-1.5%的界值时,确认非劣效性。

结果

在2023年7月3日至2024年4月7日期间,前瞻性地共纳入了1723例患者。最终分析分别纳入了AI辅助组和对照组的796例和763例患者。AI辅助组和对照组肿瘤性病变的检出率分别为3.14%和2.36%,绝对比例差异为0.78%(95%CI -0.58%至2.14%;优势比1.342 [95%CI 0.726 - 2.480])。AI辅助组的中位检查时间缩短了1.5分钟(6.18 [2.87] 对7.70 [1.90],P < 0.001)。

讨论

AI可显著缩短完整EGD的检查时间,且不影响其质量。这些发现提供了关键证据,支持AI辅助的操作完整性可作为EGD客观有效的质量指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1858/12180831/5c24fd024a78/ct9-16-e00839-s005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1858/12180831/f7b92b3d634d/ct9-16-e00839-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1858/12180831/632c4baf060d/ct9-16-e00839-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1858/12180831/a39b02edbdae/ct9-16-e00839-s004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1858/12180831/5c24fd024a78/ct9-16-e00839-s005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1858/12180831/f7b92b3d634d/ct9-16-e00839-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1858/12180831/632c4baf060d/ct9-16-e00839-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1858/12180831/a39b02edbdae/ct9-16-e00839-s004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1858/12180831/5c24fd024a78/ct9-16-e00839-s005.jpg

相似文献

1
Artificial Intelligence as a Surrogate for Inspection Time to Assess Completeness in Esophagogastroduodenoscopy: A Prospective, Randomized, Noninferiority Study.使用人工智能替代检查时间评估食管胃十二指肠镜检查的完整性:一项前瞻性、随机、非劣效性研究
Clin Transl Gastroenterol. 2025 Mar 25;16(6):e00839. doi: 10.14309/ctg.0000000000000839. eCollection 2025 Jun 1.
2
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
3
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
6
Artificial intelligence for detecting keratoconus.人工智能在圆锥角膜检测中的应用。
Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD014911. doi: 10.1002/14651858.CD014911.pub2.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
9
Polyp detection with colonoscopy assisted by the GI Genius artificial intelligence endoscopy module compared with standard colonoscopy in routine colonoscopy practice (COLO-DETECT): a multicentre, open-label, parallel-arm, pragmatic randomised controlled trial.基于 GI Genius 人工智能内镜模块的结肠镜辅助下息肉检测与常规结肠镜检查比较(COLO-DETECT):一项多中心、开放标签、平行臂、实用随机对照试验。
Lancet Gastroenterol Hepatol. 2024 Oct;9(10):911-923. doi: 10.1016/S2468-1253(24)00161-4. Epub 2024 Aug 14.
10
Screening for prostate cancer.前列腺癌筛查
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004720. doi: 10.1002/14651858.CD004720.pub3.

本文引用的文献

1
[China guideline for the screening, early detection and early treatment of gastric cancer (2022, Beijing)].《中国胃癌筛查与早诊早治指南(2022年,北京)》
Zhonghua Zhong Liu Za Zhi. 2022 Jul 23;44(7):634-666. doi: 10.3760/cma.j.cn112152-20220617-00430.
2
[China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing)].《中国食管癌筛查与早诊早治指南(2022年,北京)》
Zhonghua Zhong Liu Za Zhi. 2022 Jun 23;44(6):491-522. doi: 10.3760/cma.j.cn112152-20220517-00348.
3
The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020.
2020年食管鳞状细胞癌和食管腺癌发病率及死亡率的全球格局以及至2040年的预测:来自GLOBOCAN 2020的新估计
Gastroenterology. 2022 Sep;163(3):649-658.e2. doi: 10.1053/j.gastro.2022.05.054. Epub 2022 Jun 4.
4
The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study.2020 - 2040年185个国家胃癌的当前及未来发病率和死亡率:一项基于人群的建模研究
EClinicalMedicine. 2022 Apr 21;47:101404. doi: 10.1016/j.eclinm.2022.101404. eCollection 2022 May.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Evaluation of the effects of an artificial intelligence system on endoscopy quality and preliminary testing of its performance in detecting early gastric cancer: a randomized controlled trial.评估人工智能系统对内镜质量的影响,并初步测试其检测早期胃癌的性能:一项随机对照试验。
Endoscopy. 2021 Dec;53(12):1199-1207. doi: 10.1055/a-1350-5583. Epub 2021 Mar 4.
7
Comparing blind spots of unsedated ultrafine, sedated, and unsedated conventional gastroscopy with and without artificial intelligence: a prospective, single-blind, 3-parallel-group, randomized, single-center trial.比较未镇静超细、镇静和未镇静常规胃镜检查与有无人工智能的盲点:一项前瞻性、单盲、三平行组、随机、单中心试验。
Gastrointest Endosc. 2020 Feb;91(2):332-339.e3. doi: 10.1016/j.gie.2019.09.016. Epub 2019 Sep 18.
8
British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.英国胃肠病学会关于胃腺癌风险患者的诊断和管理指南。
Gut. 2019 Sep;68(9):1545-1575. doi: 10.1136/gutjnl-2018-318126. Epub 2019 Jul 5.
9
Randomised controlled trial of WISENSE, a real-time quality improving system for monitoring blind spots during esophagogastroduodenoscopy.随机对照试验 WISENSE,一种实时质量改进系统,用于监测食管胃十二指肠镜检查中的盲点。
Gut. 2019 Dec;68(12):2161-2169. doi: 10.1136/gutjnl-2018-317366. Epub 2019 Mar 11.
10
Artificial Intelligence Transforms the Future of Health Care.人工智能改变医疗保健的未来。
Am J Med. 2019 Jul;132(7):795-801. doi: 10.1016/j.amjmed.2019.01.017. Epub 2019 Jan 31.